MAI Capital Management’s KALA BIO KALA Stock Holding History

MAI Capital Management’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52	Hold	6	–	–	﹤0.01%	4862
2025 Q4	$167	Hold	6	–	–	﹤0.01%	4089
2025 Q3	$459	Hold	6	–	–	﹤0.01%	3632
2025 Q2	$1.43K	Hold	6	–	–	﹤0.01%	3521
2025 Q1	$1.72K	Hold	6	–	–	﹤0.01%	3006
2024 Q4	$2.08K	Buy	+6	New	+$1.89K	﹤0.01%	3027
2022 Q2	–	Sell	-29	Closed	-$100K	–	940
2022 Q1	$100K	Buy	+29	New	+$76K	﹤0.01%	857

Other funds holding KALA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MAI Capital Management's KALA Position: Q1 2026 in Review

MAI Capital Management held its KALA BIO (KALA) position steady in Q1 2026 at 6 shares worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #4862.

MAI Capital Management first reported a position in KALA in Q1 2022 and has held it in 7 quarters since. The position peaked at $100K in Q1 2022. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

MAI Capital Management held 6 shares of KALA BIO worth $52 as of Q1 2026.
MAI Capital Management left its KALA BIO share count unchanged in Q1 2026.
KALA BIO made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4862 holding.
MAI Capital Management first reported a position in KALA BIO in Q1 2022 and has held it in 7 quarters since.
MAI Capital Management's KALA BIO position peaked at $100K in Q1 2022.
28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.